Direct treatment of fetal supraventricular tachycardia after failed transplacental therapy

American Journal of Obstetrics and Gynecology

Volumn 158, Issue 3 PART 1, 1988, Pages 570-573

  Weiner, Carl P ^a   Thompson, Marietta I B ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Digoxin; endogenous digoxin like substance; fetal arrhythmia; fetal therapy

Indexed keywords

DIGITALIS LIKE FACTOR; DIGOXIN; PROCAINAMIDE; VERAPAMIL;

CASE REPORT; FEMALE; FETUS; FETUS HEART ARRHYTHMIA; FETUS TACHYCARDIA; HUMAN; PREGNANCY; PRIORITY JOURNAL;

ADULT; CASE REPORT; DIGOXIN; FEMALE; FETAL DISEASES; FETUS; HUMAN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PROCAINAMIDE; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 0023830025     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(88)90027-0     Document Type: Article

References (11)

1. In utero diagnosis and treatment of fetal supraventricular tachycardia
2. Intraventricular supraventricular tacharrythmias and transplacental digitalization
3. Serum digoxin concentrations in the human fetus, and infant
4. Transfer of digoxin across the placenta and into breast milk
5. 3H digoxin in humans
6. Transplacental cardioversion of intrauterine supraventricular tachycardia with digitalis
7. Echocardiographic diagnosis and intravenous digoxin management of fetal tachyarrythmias and congestive heart failure
8. Drug therapy in infants
9. Digoxin like immunoreactive substance in fetuses with and without cardiac pathology
10. Human fetal response to stress-plasma catecholamines and renin in continuing pregnancies
11. Clinical pharmacokinetics of procainamide